Phase II trial of arsenic trioxide and ascorbic acid with temozolomide in patients with metastatic melanoma with or without central nervous system metastases. [electronic resource]
Producer: 20080718Description: 147-51 p. digitalISSN:- 0960-8931
- Adult
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Antioxidants -- administration & dosage
- Arsenic Trioxide
- Arsenicals -- administration & dosage
- Ascorbic Acid -- administration & dosage
- Brain Neoplasms -- drug therapy
- Dacarbazine -- administration & dosage
- Female
- Humans
- Male
- Melanoma -- drug therapy
- Middle Aged
- Oxides -- administration & dosage
- Skin Neoplasms -- drug therapy
- Temozolomide
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.